Characterization of covalent adriamycin-DNA adducts.
Adriamycin is a popular antineoplastic agent whose ability to form covalent adducts with DNA has been correlated to cellular apoptosis (programmed cell death) in tumor models. We have isolated and purified this adduct formed under oxido-reductive (Fenton) conditions in Tris buffer. We show by homo- and heteronuclear NMR spectroscopy that the covalent Adriamycin-DNA adduct is structurally equivalent to that resulting from direct reaction with formaldehyde. Covalent linkage of the drug to one of the DNA strands confers remarkable stability to the duplex, indicated by a 162-fold reduction in the rate of strand displacement compared with the complex with noncovalently bound drug. Glyceraldehyde also engenders covalent Adriamycin-DNA complexes, providing a possible relevant biological context for in vivo adduct formation.
Zeman
S M
SM
Department of Chemistry, Yale University, 225 Prospect Street, New Haven, CT 06511, USA.
Phillips
D R
DR
Crothers
D M
DM
D000970:Antineoplastic Agents / Q000737:chemistry* / Q000493:pharmacokinetics; D001483:Base Sequence; D018736:DNA Adducts / Q000737:chemistry* / Q000493:pharmacokinetics; D004229:Dithiothreitol / Q000737:chemistry; D004317:Doxorubicin / Q000737:chemistry* / Q000493:pharmacokinetics; D004355:Drug Stability; D005557:Formaldehyde / Q000737:chemistry; D005985:Glyceraldehyde / Q000737:chemistry; D066298:In Vitro Techniques; D007501:Iron / Q000737:chemistry; D007700:Kinetics; D009682:Magnetic Resonance Spectroscopy; D010084:Oxidation-Reduction; D014325:Tromethamine
D000970:Antineoplastic Agents; D018736:DNA Adducts; C031902:doxorubicin-DNA; D014325:Tromethamine; D005557:Formaldehyde; D005985:Glyceraldehyde; D004317:Doxorubicin; D007501:Iron; D004229:Dithiothreitol